Nebraska Medicaid program

Welcome to the website for the Nebraska Medicaid Pharmacy Program - Point of Sale System (POS). The Nebraska Department of Health and Human Services, Medicaid and Long Term Care division has contracted with Magellan Medicaid Administration, Inc. as the Nebraska Pharmacy Benefits Administrator.

Nebraska Medicaid provides for health care services to eligible elderly and disabled individuals and eligible low-income pregnant women, children and parents. Medicaid provides health care for more than one in every ten Nebraskans.

Magellan Medicaid Administration, Inc. is responsible for:

• Operations Support of the Point of Sale System
• Call Center Operations for Providers
• Clinical Consultation Services
• Education and outreach activities for Providers

July 2018

May 2018 P&T Preferred Drug List (PDL) Now Available

The Preferred Drug List (PDL) decided by the Nebraska Pharmaceutics & Therapeutics (P&T) Committee and approved by the NE DHHS, is now available and will go into effect on Thursday, July 19, 2018. The updated list can be found at:
https://nebraska.fhsc.com/PDL/PDLlistings.asp

Providers of Fee-for-Service (FFS) members may contact Magellan Medicaid Administration via phone or fax to document patient specific clinical considerations requiring exception to these limits.

Magellan Medicaid Administration, Inc:

• Fax 1-866-759-4115
• Tel 1-800-241-8335

Preferred Drug List (PDL)/Claim Limitations Document Updates

The Preferred Drug List (PDL) and Claim Limitations Document have been updated with changes through July 1, 2018. The updated lists can be found at:
https://nebraska.fhsc.com/downloads/NEClaimLimitations.pdf
https://nebraska.fhsc.com/PDL/PDLlistings.asp

Providers of Fee-for-Service (FFS) members may contact Magellan Medicaid Administration via phone or fax to document patient specific clinical considerations requiring exception to these limits.

Magellan Medicaid Administration, Inc:

• Fax 1-866-759-4115
• Tel 1-800-241-8335

June 2018

May 2018 P&T Preferred Drug List (PDL) Now Available

The Preferred Drug List (PDL) decided by the Nebraska Pharmaceutics & Therapeutics (P&T) Committee and approved by the NE DHHS, is now available and will go into effect on Thursday, July 19, 2018. The updated list can be found at:
https://nebraska.fhsc.com/PDL/PDLlistings.asp

Providers of Fee-for-Service (FFS) members may contact Magellan Medicaid Administration via phone or fax to document patient specific clinical considerations requiring exception to these limits.

Magellan Medicaid Administration, Inc:

• Fax 1-866-759-4115
• Tel 1-800-241-8335

Preferred Drug List (PDL)/Claim Limitations Document Updates

The Preferred Drug List (PDL) and Claim Limitations Document have been updated with changes through June 1, 2018. The updated lists can be found at:
https://nebraska.fhsc.com/downloads/NEClaimLimitations.pdf
https://nebraska.fhsc.com/PDL/PDLlistings.asp

Providers of Fee-for-Service (FFS) members may contact Magellan Medicaid Administration via phone or fax to document patient specific clinical considerations requiring exception to these limits.

Magellan Medicaid Administration, Inc:

• Fax 1-866-759-4115
• Tel 1-800-241-8335

May 2018

Preferred Drug List (PDL)/Claim Limitations Document Updates

The Preferred Drug List (PDL) and Claim Limitations Document have been updated with changes through May 1, 2018. The updated lists can be found at:
https://nebraska.fhsc.com/downloads/NEClaimLimitations.pdf
https://nebraska.fhsc.com/PDL/PDLlistings.asp

Providers may contact Magellan Medicaid Administration via phone or fax to document patient specific clinical considerations requiring exception to these limits.

Magellan Medicaid Administration, Inc:

• Fax 1-866-759-4115
• Tel 1-800-241-8335

April 2018

Preferred Drug List (PDL)/Claim Limitations Document Updates

The Preferred Drug List (PDL) and Claim Limitations Document have been updated with changes through April 1, 2018. The updated lists can be found at:
https://nebraska.fhsc.com/downloads/NEClaimLimitations.pdf
https://nebraska.fhsc.com/PDL/PDLlistings.asp

Providers may contact Magellan Medicaid Administration via phone or fax to document patient specific clinical considerations requiring exception to these limits.

Magellan Medicaid Administration, Inc:

• Fax 1-866-759-4115
• Tel 1-800-241-8335

March 2018

Preferred Drug List (PDL)/Claim Limitations Document Updates

The Preferred Drug List (PDL) and Claim Limitations Document have been updated with changes through March 1, 2018. The updated lists can be found at:
https://nebraska.fhsc.com/downloads/NEClaimLimitations.pdf
https://nebraska.fhsc.com/PDL/PDLlistings.asp

Providers may contact Magellan Medicaid Administration via phone or fax to document patient specific clinical considerations requiring exception to these limits.

Magellan Medicaid Administration, Inc:

• Fax 1-866-759-4115
• Tel 1-800-241-8335

January 2018

November 2017 P&T Preferred Drug List (PDL) Now Available

The Preferred Drug List (PDL) decided by the Nebraska Pharmaceutics & Therapeutics (P&T) Committee and approved by the NE DHHS, is now available and will go into effect on Thursday, January 25, 2018. The updated list can be found at:
https://nebraska.fhsc.com/PDL/PDLlistings.asp

Providers of Fee-for-Service (FFS) members may contact Magellan Medicaid Administration via phone or fax to document patient specific clinical considerations requiring exception to these limits.

Magellan Medicaid Administration, Inc:

• Fax 1-866-759-4115
• Tel 1-800-241-8335

Preferred Drug List (PDL)/Claim Limitations Document Updates

The Preferred Drug List (PDL) and Claim Limitations Document have been updated with changes through January 1, 2018. The updated lists can be found at:
https://nebraska.fhsc.com/downloads/NEClaimLimitations.pdf
https://nebraska.fhsc.com/PDL/PDLlistings.asp

Providers may contact Magellan Medicaid Administration via phone or fax to document patient specific clinical considerations requiring exception to these limits.

Magellan Medicaid Administration, Inc:

• Fax 1-866-759-4115
• Tel 1-800-241-8335